Solid lipid nanoparticles for parenteral drug delivery.
By S. Wissing, O. Kayser, R. Müller. Advanced Drug Delivery Reviews, 2004
1,432 citations recorded by the source corpus.
Subfields: Food Science, Molecular Biology, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/1505a8424d0e638ea15b0380a72d108f4e003b96
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Food Science
- D. McClements
- Jiajia Rao
- E. Decker
- J. Weiss
- Yeonhwa Park
- Phatsapong Yingchoncharoen
- M. Üner
- Surajit Das
In Molecular Biology
- D. McClements
- Jiajia Rao
- Phatsapong Yingchoncharoen
- W. Charman
- M. Üner
- Surajit Das
- J. Weiss
- Colin W. Pouton
In Pharmaceutical Science
- D. McClements
- Jiajia Rao
- Christopher J. H. Porter
- W. Charman
- Natalie L. Trevaskis
- S. Charman
- H. Williams
- R. Shanker
Citations in the corpus
- Structural Design Principles for Delivery of Bioactive Components in Nutraceuticals and Functional Foods (2009, background): “The lipids used to form SLP are typically highly purified triglycerides, complex glyceride mixtures, or even waxes (Wissing et al., 2004; Dubes et al., 2003) but should be at least partly solid at ambient or storage temperature.”
- Strategies to Address Low Drug Solubility in Discovery and Development (2013, background): “SLNs combine the advantages of colloidal delivery systems such as liposomes, lipid emulsions, and polymeric nanoparticles (Müller et al., 2000; Wissing et al., 2004), with the potential for facile large-scale production and a favorable tolerability profile for most core lipid components (Müller et…”
- Biocompatibility of engineered nanoparticles for drug delivery. (2013, neutral): “[151].”
- Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, background): “Apart from offering the advantages of physical stability, protection of labile drug degeneration, controlled release, and easy preparation (Wissing et al., 2004), SLNs can also be produced through economical largescale production and exhibit fewer drug storage and leakage problems compared with…”
- Drug delivery systems: An updated review (2012, background): “Cross linked dextran beads were developed as a carrier for development of a single contact vaccine delivery system.[50-54] There has been extensive research on drug delivery by biodegradable polymeric devices since bioresorbable surgical sutures entered the market two decades ago.”
- Food-Grade Nanoemulsions: Formulation, Fabrication, Properties, Performance, Biological Fate, and Potential Toxicity (2011, background): “The oil droplets can then be crystallized after their formation by cooling the nanoemulsion sufficiently below the melting temperature of the lipid (Walstra, 2003; Muller and Keck, 2004; Wissing et al., 2004; McClements, 2005).”
- Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives (2007, methodology): “This paper basicly reviews types of SLN, principles of drug loading and models of drug incorporation.”